Markus Puhlmann, M.D., is a distinguished medical professional currently serving as the Chief Medical Officer at PERSPECTIVE THERAPEUTICS INC. Dr. Puhlmann's career in medicine and oncology spans several decades, marked by significant contributions to the field of cancer research and treatment. He earned his medical degree from the University of Freiburg in Germany, followed by specialized training in surgery and oncology at renowned institutions in the United States and Europe. His expertise in developing and implementing clinical trials has been pivotal in advancing novel cancer therapies. Throughout his career, Dr. Puhlmann has held various leadership positions in both academic and industry settings. He has been instrumental in the development of several innovative cancer treatments, particularly in the realm of targeted therapies and radiopharmaceuticals. His work has been published in numerous peer-reviewed journals, and he has presented at international conferences, earning recognition for his contributions to oncology. At PERSPECTIVE THERAPEUTICS INC, Dr. Puhlmann leads the clinical development strategy, overseeing the design and execution of clinical trials aimed at bringing new cancer treatments to patients. His role is crucial in ensuring that the company's therapeutic candidates meet rigorous scientific and regulatory standards, ultimately improving patient outcomes.